IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 50 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $19,000 | +46.2% | 49,876 | +70.9% | 0.00% | +100.0% |
Q2 2022 | $13,000 | -43.5% | 29,179 | -37.1% | 0.00% | -50.0% |
Q1 2022 | $23,000 | -94.1% | 46,368 | -85.7% | 0.00% | -94.7% |
Q2 2021 | $390,000 | +104.2% | 325,330 | +120.9% | 0.04% | +171.4% |
Q1 2021 | $191,000 | +377.5% | 147,252 | +568.2% | 0.01% | +250.0% |
Q4 2019 | $40,000 | +21.2% | 22,038 | +84.8% | 0.00% | +100.0% |
Q4 2018 | $33,000 | – | 11,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |